WINNINGHAM RICK E (Chief Executive Officer) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/17/2024ACC: 0001415889-24-013612
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+2.07K
Net shares
Net buyer
$20.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.07K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+2.07K
Price / share
$9.85
Trade value
$20.37K
% of position
0.1%
5/15/2024
1.85M→1.85M
Total
Net shares
+2.07K
Net value
$20.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/15/2024 | A · Award | +2.07K | $9.85 | $20.37K | 0.1% | 1.85M | 1.85M |
| Total | +2.07K | $20.37K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned92.57K
Ordinary Shares
IndirectShares owned3.90K
Total
96.47K indirect96.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Ordinary Shares | 3.90K | Indirect |
| Total | 96.47K | 96.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported